BiotechTube

Oxymetazoline HCL 1.0% Cream

ApprovedCompleted
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Rosacea

Conditions

Rosacea

Trial Timeline

Dec 4, 2017 → Jun 15, 2018

NCT ID
NCT03380390

About Oxymetazoline HCL 1.0% Cream

Oxymetazoline HCL 1.0% Cream is a approved stage product being developed by Aclaris Therapeutics for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT03380390. Target conditions include Rosacea.

Hype Score Breakdown

Clinical
30
Activity
20
Company
2
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT03380390ApprovedCompleted

Competing Products

20 competing products in Rosacea

See all competitors
ProductCompanyStageHype Score
Lotilaner Gel, 2.0%Tarsus PharmaceuticalsPhase 2
47
lotilaner + VehicleTarsus PharmaceuticalsPhase 2
47
DRM02Eli LillyPhase 2
52
Clascoterone Cream 1%Sun PharmaceuticalPhase 2
52
Metronidazole Topical Gel 1% + Metronidazole Topical Gel 1% (Metrogel) + PlaceboSun PharmaceuticalPhase 1
33
Azelaic Acid 15% topical gel + Finacea® (azelaic acid) Gel, 15% + PlaceboSun PharmaceuticalPhase 1
33
Azelaic acid foam 15% + Finacea® (Azelaic acid Foam) 15% + Vehicle of the test productSun PharmaceuticalPhase 1
33
Laropiprant + Placebo for LaropiprantMerckPhase 1
33
AMG 334NovartisPhase 2
52
BFH772 1% ointment + Vehicle ointment + Noritate® 1% creamNovartisPhase 2
52
Deucravacitinib + PlaceboBristol Myers SquibbPhase 2
51
Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
82
Coppertone, BAY1183345BayerPre-clinical
20
Azelaic acid 15% + Brimonidine 0.33%BayerApproved
82
Azelaic Acid foam 15%BayerApproved
82
Azelaic Acid (Finacea Foam, BAY39-6251)BayerPre-clinical
20
Azelaic acid + Vehicle foamBayerPhase 2
49
Azelaic acid foam 15% + Vehicle foamBayerPhase 2
49
Azelaic acidBayerPre-clinical
20
azelaic acid 15% gel + azelaic acid 15% gelBayerApproved
82

Other Products from Aclaris Therapeutics

A-101 Topical SolutionApproved
77
A-101Phase 3
69
A-101 SolutionPhase 3
69
A-101 SolutionPhase 3
69
ActivePhase 3
69